There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

The weight-loss jab Wegovy made its debut on June 4 2021 . It was the first new weight-loss drug to be approved by the US ...

Go Fish: According to the folks at New York’s Hospital for Special Surgery ... This compound widens arteries for improved ...

From November 11 to 14, 2024, Singclean showcased its cutting-edge medical and skincare innovations at MEDICA, the world's ...

Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments ...

Dr. Carrie Jose, in her latest Health and Wellness column, explains what your doctor may miss about your pain’s true source ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

About Osteoarthritis (OA) of the Knee Osteoarthritis ... ("Capsida") today announced new preclinical data for CAP-004, a potential best-in-class systemically administered next-generation gene therapy ...